Literature DB >> 281939

Significance of genetic factors in Gilles de la Tourette syndrome: a review.

R S Wilson, D C Garron, H L Klawans.   

Abstract

Observations suggesting a genetic basis for Gilles de la Tourette syndrome are reviewed with particular emphasis on the finding of familial aggregation. Studies of both Tourette syndrome and simple tic have found that approximately 30% of patients have a positive family history of tic. The significance of this figure depends on a number of factors, in particular the prevalence of positive tic histories in the population. If the latter figure is 10%, which the best available evidence suggests is a reasonable estimate, approximately 30% of families in the general population would be expected to contain at least one present or former tiquer. It is argued, therefore, that the family aggregation findings in Tourette syndrome do not support the hypothesis that the condition has a significant genetic component. Methodological considerations for future research are discussed.

Entities:  

Mesh:

Year:  1978        PMID: 281939     DOI: 10.1007/bf01067479

Source DB:  PubMed          Journal:  Behav Genet        ISSN: 0001-8244            Impact factor:   2.805


  30 in total

1.  An epidemiologic study of behavior characteristics in children.

Authors:  R LAPOUSE; M A MONK
Journal:  Am J Public Health Nations Health       Date:  1958-09

2.  Gilles de la Tourette syndrome: clinical and genetic studies in a midwestern city.

Authors:  E R Wassman; R Eldridge; S Abuzzahab; L Nee
Journal:  Neurology       Date:  1978-03       Impact factor: 9.910

3.  Further observations on Tourette's syndrome.

Authors:  K B Corbin; J R Feild; N P Goldstein; D W Klass
Journal:  Proc Aust Assoc Neurol       Date:  1968

4.  Clinical psychological testing in Tourette's syndrome.

Authors:  E Shapiro; A K Shapiro; J Clarkin
Journal:  J Pers Assess       Date:  1974-10

5.  Gilles de la Tourette's syndrome.

Authors:  J R Feild; K B Corbon; N P Goldstein; D W Klass
Journal:  Neurology       Date:  1966-05       Impact factor: 9.910

6.  Neurological features of Gilles de la Tourette's syndrome.

Authors:  R D Sweet; G E Solomon; H Wayne; E Shapiro; A K Shapiro
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-02       Impact factor: 10.154

Review 7.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

8.  A clinical study of Gilles de la Tourette's disease (maladie des tics) in children.

Authors:  L EISENBERG; E ASCHER; L KANNER
Journal:  Am J Psychiatry       Date:  1959-02       Impact factor: 18.112

9.  Gilles de la Tourette's syndrome: clinical, genetic, psychologic, and biochemical aspects in 21 selected families.

Authors:  R Eldridge; R Sweet; R Lake; M Ziegler; A K Shapiro
Journal:  Neurology       Date:  1977-02       Impact factor: 9.910

10.  Gilles de la Tourette's syndrome. Familial occurrence and precipitation by methylphenidate therapy.

Authors:  M A Pollack; N L Cohen; A J Friedhoff
Journal:  Arch Neurol       Date:  1977-10
View more
  3 in total

1.  Gilles de la Tourette's syndrome in monozygotic twins.

Authors:  J Waserman; S Lal; S Gauthier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-01       Impact factor: 10.154

2.  Detection of major gene for Gilles de la Tourette syndrome.

Authors:  D E Comings; B G Comings; E J Devor; C R Cloninger
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

3.  Genetic analysis of Tourette syndrome suggesting major gene effect.

Authors:  M Baron; E Shapiro; A Shapiro; J D Rainer
Journal:  Am J Hum Genet       Date:  1981-09       Impact factor: 11.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.